Oral Fluids Laboratory Testing Services Sample Clauses

Oral Fluids Laboratory Testing Services. Item # Type of Testing Service (As detailed in Section III.F, Scope of Work, Oral Fluids Laboratory Testing Services) Unit Unit Price 2.a 6-panel initial screening (Marijuana (THC), Cocaine, Opiates, Amphetamines, Methamphetamines, and Oxycodone) Per test $4.25 2.a.1 6-panel drug confirmation testing (GCMS) Per test $2.50 2.b 7-panel initial screening (Amphetamines, Benzodiazepines, Cocaine, Methamphetamines, Methadone, Opiates, THC) Per test $5.25 2.b.1 7-panel drug confirmation testing Per test $2.50 2.c 8-panel initial screening (Amphetamines, Benzodiazepines, Cocaine, Methamphetamines, Methadone, Opiates, THC, Oxycodone) Per test $6.25 2.c.1 8-panel drug confirmation testing Per test $2.50 2.d 11-panel initial screening (K2/spice) (Alcohol, Amphetamines, Barbiturates, Benzodiazepines, Cocaine, Methamphetamines, Methadone, Opiates, Oxycodone, THC, K2/spice) Per test $24.00 2.d.1 11-panel drug confirmation testing (K2/spice) Per test $2.50 2.e 11-panel initial screening (Phencyclidine) (Alcohol, Amphetamines, Barbituates, Benzodiazepines, Cocaine, Methamphetamines, Methadone, Opiates, Oxycodone, THC, Phencyclidine) Per test $6.75 2.e.1 11-panel drug confirmation testing (Phencyclidine) Per test $2.50 2.f Methadone (GCMS): Initial screening Per test $1.25 2.f.1 Methadone (GCMS): Drug confirmation testing Per test $2.50 2.g Synthetic Cannabinoids (K2/spice): Initial screening Per test $15.00 2.g.1 Synthetic Cannabinoids (K2/spice): Drug confirmation testing Initial screening is performed by LC/MS/MS. Confirmation testing is not required $0.00 2.h Opiates (Hydrocodone): Drug confirmation testing Per test $2.50
AutoNDA by SimpleDocs

Related to Oral Fluids Laboratory Testing Services

  • Laboratory Testing All laboratories selected by UPS Freight for analyzing Controlled Substances Testing will be HHS certified.

  • Drug Testing (A) The state and the PBA agree to drug testing of employees in accordance with section 112.0455, F.S., the Drug-Free Workplace Act.

  • Diagnostic procedures to aid the Provider in determining required dental treatment.

  • Random Testing Notwithstanding any provisions of the Collective Agreement or any special agreements appended thereto, section 4.6 of the Canadian Model will not be applied by agreement. If applied to a worker dispatched by the Union, it will be applied or deemed to be applied unilaterally by the Employer. The Union retains the right to grieve the legality of any imposition of random testing in accordance with the Grievance Procedure set out in this Collective Agreement.

  • Random Drug Testing All employees covered by this Agreement shall be subject to random drug testing in accordance with Appendix D.

  • Technology Research Analyst Job# 1810 General Characteristics Maintains a strong understanding of the enterprise’s IT systems and architectures. Assists in the analysis of the requirements for the enterprise and applying emerging technologies to support long-term business objectives. Responsible for researching, collecting, and disseminating information on emerging technologies and key learnings throughout the enterprise. Researches and recommends changes to foundation architecture. Supports research projects to identify and evaluate emerging technologies. Interfaces with users and staff to evaluate possible implementation of the new technology in the enterprise, consistent with the goal of improving existing systems and technologies and in meeting the needs of the business. Analyzes and researches process of deployment and assists in this process.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • ODUF Testing 6.6.1 Upon request from TWTC, AT&T shall send ODUF test files to TWTC. The Parties agree to review and discuss the ODUF file content and/or format. For testing of usage results, AT&T shall request that TWTC set up a production (live) file. The live test may consist of TWTC’s employees making test calls for the types of services TWTC requests on ODUF. These test calls are logged by TWTC, and the logs are provided to AT&T. These logs will be used to verify the files. Testing will be completed within thirty (30) days from the date on which the initial test file was sent.

  • Product Testing Upon request, Customer shall provide Operator a laboratory report for each Product delivery by Customer or Customer’s supplier. Operator will not be obligated to receive Contaminated Product for throughput through the Pipelines, nor will Operator be obligated to accept Product that fails to meet the applicable quality specifications for the Berths under the BAUTA and any Terminal Service Orders issued thereunder.

  • Laboratory Services Covered Services include prescribed diagnostic clinical and anatomic pathological laboratory services and materials when authorized by a Member's PCP and HPN’s Managed Care Program.

Time is Money Join Law Insider Premium to draft better contracts faster.